TY - JOUR
T1 - Inherited Disorders of Hemostasis in Dogs and Cats
AU - Barr, James W.
AU - McMichael, Maureen
PY - 2012/5
Y1 - 2012/5
N2 - Inherited disorders of hemostasis encompass abnormalities in primary hemostasis, coagulation, and fibrinolysis resulting from genetic mutations. There is significant variation in the phenotype expressed ranging from life limiting to the absence of overt clinical signs. Von Willebrand disease is the most common primary hemostatic disorder in dogs, and hemophilia A is the most common coagulation factor disorder. The diagnosis of inherited bleeding disorders is made by functional and/or quantitative evaluation. Genetic testing has added to the knowledge base, allowing prevention through targeted breeding. Avoidance of trauma and injury is paramount in the prevention of bleeding in animals diagnosed with inherited hemostatic disorders. Current therapeutic options include platelet transfusions, broad replacement of coagulation factors (e.g., plasma), targeted factor replacement (e.g., cryoprecipitate), antifibrinolytic agents and specific factor replacement, and treatment of the symptoms (i.e., bleeding) with blood transfusions.
AB - Inherited disorders of hemostasis encompass abnormalities in primary hemostasis, coagulation, and fibrinolysis resulting from genetic mutations. There is significant variation in the phenotype expressed ranging from life limiting to the absence of overt clinical signs. Von Willebrand disease is the most common primary hemostatic disorder in dogs, and hemophilia A is the most common coagulation factor disorder. The diagnosis of inherited bleeding disorders is made by functional and/or quantitative evaluation. Genetic testing has added to the knowledge base, allowing prevention through targeted breeding. Avoidance of trauma and injury is paramount in the prevention of bleeding in animals diagnosed with inherited hemostatic disorders. Current therapeutic options include platelet transfusions, broad replacement of coagulation factors (e.g., plasma), targeted factor replacement (e.g., cryoprecipitate), antifibrinolytic agents and specific factor replacement, and treatment of the symptoms (i.e., bleeding) with blood transfusions.
KW - Coagulation
KW - Hemophilia
KW - Hemostasis
KW - Von Willebrand disease
UR - http://www.scopus.com/inward/record.url?scp=84867000894&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867000894&partnerID=8YFLogxK
U2 - 10.1053/j.tcam.2012.07.006
DO - 10.1053/j.tcam.2012.07.006
M3 - Review article
C2 - 23031456
AN - SCOPUS:84867000894
SN - 1938-9736
VL - 27
SP - 53
EP - 58
JO - Topics in Companion Animal Medicine
JF - Topics in Companion Animal Medicine
IS - 2
ER -